Finance

Lists
Why is GMED down २.७०%?
Dive Deeper
GMED:NYSE
Globus Medical Inc
US$ ७६.७१
-२.७०%
(-२.१३) 1D
US$ ७६.७१
०.००% (०.००)
After hours
Closed: अक्टोबर १६, १६:००:०७ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GMED...
Open
US$ ७९.३५
High
US$ ७९.९५
Low
US$ ७६.४९
Mkt. cap
१०.३० अरब
Avg. vol.
१५.७८ लाख
Volume
१९.४० लाख
P/E ratio
१९.६१
52-wk high
US$ १०१.४०
52-wk low
US$ ५८.५१
EPS
US$ ३.९१
Beta
०.९६
Shares outstanding
११.२६ करोड
No. of employees
६ हजार
Open
US$ ७९.३५
High
US$ ७९.९५
Low
US$ ७६.४९
Mkt. cap
१०.३० अरब
Avg. vol.
१५.७८ लाख
Volume
१९.४० लाख
P/E ratio
१९.६१
52-wk high
US$ १०१.४०
52-wk low
US$ ५८.५१
EPS
US$ ३.९१
Beta
०.९६
Shares outstanding
११.२६ करोड
No. of employees
६ हजार
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
९ घण्टा पहिले
Stifel keeps USD 76.43 target for Globus Medical stock
Profile
Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders. Wikipedia
About Globus Medical Inc
CEOKeith Pfeil
Employees६ हजार
Founded२००३
Headquarters-
Sector-
Analyst ratings
Based on 13 analysts giving stock ratings to GMED in the past 3 months
Buy
Buy
9
Hold
4
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for GMED in the last 3 months.
Highest
Current US$ ७६.७१
US$ ११७.०० (+५२.५२%)
Average
US$ ९८.७५ (+२८.७३%)
Lowest
US$ ८२.०० (+६.९०%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Stephan
Stifel Nicolaus
Hold
Reiterated
US$ ८५.००
+१०.८%
10/07/2026
Kendall Au
RBC Capital
Buy
Maintained
US$ ८५.००
+१०.८%
10/01/2026
Shagun Singh Chadha
RBC Capital
Buy
Maintained
US$ ८५.००
+१०.८%
10/01/2026
Ryan Zimmerman
BTIG
Hold
Maintained
-
-
09/18/2026
Vik Chopra
BMO Capital
Buy
Maintained
US$ ९४.००
+२२.५%
08/27/2026
Caitlin Roberts
Canaccord Genuity
Buy
Reiterated
US$ ११५.००
+४९.९%
08/28/2026
Keith Hinton
Freedom Capital Markets
Hold
Maintained
US$ ८७.००
+१३.४%
08/27/2026
Travis Steed
Bank of America Securities
Buy
Maintained
US$ १०६.००
+३८.२%
08/19/2026
Richard Newitter
Truist Financial
Buy
Reiterated
US$ १००.००
+३०.४%
08/07/2026
Matthew O'Brien
Piper Sandler
Buy
Maintained
US$ १००.००
+३०.४%
08/07/2026
David Saxon
Needham
Buy
Reiterated
US$ ११७.००
+५२.५%
08/07/2026
Rishi Jaluria
RBC Capital
Buy
Maintained
US$ ११५.००
+४९.९%
08/06/2026
Larry Biegelsen
Wells Fargo
Buy
Maintained
US$ ९९.००
+२९.१%
08/07/2026
Mathew Blackman
TD Cowen
Buy
Maintained
US$ ११५.००
+४९.९%
08/06/2026
Unknown Analyst
UBS
Hold
Initiated
US$ ८२.००
+६.९%
07/28/2026
Patrick Wood
UBS
Hold
Initiated
US$ ८२.००
+६.९%
07/28/2026
Unknown Analyst
BMO Capital
Buy
Initiated
US$ ९४.००
+२२.५%
07/09/2026
Matt Miksic
Barclays
Buy
Maintained
US$ १२३.००
+६०.३%
05/11/2026
Caitlin Cronin
Canaccord Genuity
Buy
Reiterated
US$ ११५.००
+४९.९%
05/08/2026
Last report
२०२६ अगस्ट ६
Fiscal period
Q2 2026
US$ १.३४ / US$ १.१०
+२१.९१%beat
Revenue / Est. (USD)
७८.९६ करोड / ७८.३० करोड
+०.८५%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
७६.९० करोड
८२.६४ करोड
७५.९९ करोड
७८.९६ करोड
Cost of goods sold
२४.६१ करोड
२५.४६ करोड
२३.४१ करोड
२४.१४ करोड
Cost of revenue
२४.६१ करोड
२५.४६ करोड
२३.४१ करोड
२४.१४ करोड
Research and development expenses
३.८१ करोड
३.६२ करोड
३.६५ करोड
३.६३ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२८.४२ करोड
३०.४८ करोड
२९.७८ करोड
२८.६८ करोड
Operating expense
३५.२१ करोड
३७.०३ करोड
३६.३८ करोड
३५.२७ करोड
Total operating expenses
५९.८२ करोड
६२.४९ करोड
५९.७९ करोड
५९.४१ करोड
Operating income
१७.०८ करोड
२०.१५ करोड
१६.२० करोड
१९.५५ करोड
Other non operating income
१५.३७ लाख
८.६५ लाख
२२.४७ लाख
११.७१ लाख
EBT including unusual items
१४.४० करोड
१६.९२ करोड
१५.७१ करोड
१८.९८ करोड
EBT excluding unusual items
१७.३६ करोड
१९.८५ करोड
१६.७५ करोड
२०.२९ करोड
Income tax expense
२.५० करोड
२.८६ करोड
३.२८ करोड
३.८२ करोड
Effective tax rate
१७.३८%
१६.९२%
२०.८६%
२०.१५%
Other operating expenses
-
-
-
-
Net income
११.९० करोड
१४.०६ करोड
१२.४३ करोड
१५.१६ करोड
Net profit margin
१५.४७%
१७.०१%
१६.३६%
१९.२०%
Earnings per share
१.१८
१.२८
१.१२
१.३४
Interest and investment income
१४.५५ लाख
३३.१२ लाख
५४.३४ लाख
७०.७४ लाख
Interest expense
-
-
-
-
Net interest expenses
१४.५५ लाख
३३.१२ लाख
५४.३४ लाख
७०.७४ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
२४.२० करोड
२७.०३ करोड
२३.१९ करोड
२६.५१ करोड
Gain or loss from assets sale
२३.०७ लाख
४०.८७ लाख
२४.४९ लाख
३१.०९ लाख
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू